The Global Cardiac Marker Testing Market is projected to reach USD 5.5 billion by 2027 from USD 3.6 billion in 2020, at a CAGR of 8%.
Cardiac markers include various forms of enzymes, hormones, and proteins such as cardiac troponin, creatine kinase (CK), ischemia-modified albumin (IMA), and myoglobin. Measurement of these biomarkers helps diagnose various cardiac syndromes, such as acute coronary syndrome, cardiac ischemia, and blockage of blood flow to the heart. In hemolytic anemia, creatine kinase, stroke, pancreatitis, ischemic cardiomyopathy, and many other diseases, lactate dehydrogenase (LDH) is a nonspecific marker for myocardial/infarction and its concentrations may be elevated. Cardiac markers are used to treat and stratify the risk of patients with chest pain and presumptive coronary acute syndrome (ACS). Usually, doctors do several tests for heart markers over several hours to track elevated blood levels and to understand the severity of the heart attack. Cardiac marker testing is gaining momentum worldwide because it provides greater specificity and can identify troponin-like conditions at an early stage of presentation.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Cardiac Marker Testing Market at:
https://www.orionmarketreports.com/request-sample/?id=58432
Company Profile
Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), Danaher Corporation (US), bioMérieux SA (France), LSI Medience Corporation (Japan), Ortho Clinical Diagnostics (US), Randox laboratories Ltd. (UK), Guangzhou Wondfo Biotech Co., Ltd (China), DiaSorin S.p.A. (Italy), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), PerkinElmer Inc. (US), Thermo Fisher Scientific Inc. (US), and Tosoh Corporation (Japan)
Market Segmentation
By Biomarker Type
- Troponin I and T
- CK-MB
- Bnp or Nt-Probnp
- Myoglobin
- Hscrp
- Other Biomarkers
By Disease
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Ischemia
Scope of the Report
The research study analyzes the global Cardiac Marker Testing industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
A full report of Global Cardiac Marker Testing Market is available at:
https://www.orionmarketreports.com/cardiac-marker-testing-market/58432/
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Cardiac Marker Testing Market Report
1. What was the Cardiac Marker Testing Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of Cardiac Marker Testing Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Cardiac Marker Testing Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Cardiac Marker Testing market.
• The market share of the global Cardiac Marker Testing market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Cardiac Marker Testing market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Cardiac Marker Testing market.
For more customized data, request for report customization @
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
(This release has been published on Global Market Post.
Global Market Post is not responsible for any content included in this release.)
